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Abstract
Candida albicans is a fungal pathogen that is dangerous when it enters the bloodstream
and as it can cause Candidiasis. Candidiasis lethality in immunocompromised 
individuals and C. albicans antifungal drug resistance has made it critical that we 
understand C. albicans biology at a molecular level. Ume6 is a transcription factor 
important for C. albicans filamentous growth and virulence. For this project, I used 
CRISPR-mediated mutagenesis to create and characterize mutants that substituted two
conserved positively charged lysines with two negatively charged glutamates and 
truncated Ume6 upstream of the Zn2+ finger DNA binding and C-terminal domains. 
Using filamentation assays, I demonstrated that there is decreased filamentous growth 
with truncation and glutamate substitution mutations upstream of the Ume6 Zn2+ finger 
DNA binding domain. Using virulence tests with Galleria mellonella larvae, I 
demonstrated that there is decreased mortality with truncation and glutamate 
substitution mutations upstream of the Ume6 Zn2+ finger DNA binding domain. Our data 
supported the hypothesis that the Ume6 Zn2+ finger DNA binding domain is important for
filamentous growth regulation and virulence.
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Process Analysis Statement
The goal of this project was to understand the importance of the Ume6 Zn2+ 
finger DNA binding and C-terminal domains in Candida albicans filamentous growth. 
This was done by creating and characterizing C. albicans strains with altered residues 
upstream of the Zn2+ finger DNA binding domain and C-terminal domain. I performed 
filamentation assays and virulence tests with Galleria mellonella larvae to determine the
effects of glutamate substitution and truncations upstream of Ume6 Zn2+ finger DNA 
binding domain and C-terminal domain had on filamentous growth.
My time as a Research Assistant in the Bernstein Lab has taught me many of the
technical skills necessary in research, including how to design and carry out my own 
experiments. I have applied CRISPR-mediated genome editing for the past two years 
with the last year focusing on creating and characterizing mutants in UME6. I have been
trained in primer design, DNA recombination, gel electrophoresis, competent cell 
transformations, C. albicans transformations, colony PCR, restriction digestion 
screening, filamentation assay plating, and G. mellonella injections as a Research 
Assistant in the Bernstein lab, and I used all these skills to carry out my thesis project. 
For example, I used SnapGene software and our lab databases to design repair 
template primers to create and insert the mutations into UME6. The repair templates 
were designed with restriction sites for screening. Failure to design the primers correctly
can result in ineffective restriction enzyme screening and inability to identify the 
mutation.
Throughout my application of CRISPR with C. albicans, I learned that failure is 
often more prevalent than success. It takes weeks to perform a C. albicans 
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transformation, confirm mutants, and characterize strain phenotypes. If a problem were 
identified in any of these procedures, weeks of work would be lost. These problems 
provided opportunities to learn how to troubleshoot and tackle unexpected outcomes. 
For example, I was having trouble confirming the UME6EE mutant. After discussion with
Dr. Bernstein, an agarose gel with purified and unpurified colony PCR was ran to look 
for any difference in DNA amplification in each sample. I used gel electrophoresis to 
determine that there was no DNA in the purified colony PCR sample. The protocol for 
the project was modified to remove the purification step and a successful UME6EE 
mutant was confirmed.
Research is a social experience with discussion and presentation of data at 
various conferences and presentations. I presented my thesis work at the Midwest 
Yeast Conference at Northwestern University in Chicago, Illinois during the fall 
semester of my senior year. That spring, I presented at the 2019 Student Symposium at
Ball State University in Muncie, Indiana, and the Undergraduate Research Conference 
at Butler University in Indianapolis, Indiana. Through these conferences, I learned how 
to effectively communicate and discuss my research to a variety of audiences. For 
example, a student more versed in computer science than biology came up to me and 
asked about my work. I explained my work to him in a way that reflected understanding 
and generated relevant questions, and he seemed to understand the project’s methods 
and results. It is very useful in this field to understand how to discuss research with a 
variety of audiences.
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Dissection of UME6 Point and Truncation Mutants Effects on C. albicans 
Filamentous Growth
Introduction
Candida albicans is an opportunistic human fungal pathogen, but its growth is 
controlled through a healthy immune response [1]. Immunocompromised individuals 
have a weakened immune response to the pathogen, and the infection can reach the 
bloodstream. The infection spreads to other solid tissues causing a lethal systemic 
infection called Candidiasis [2]. With over four million global cases of infection reported 
annually, there is an increasing concern with Candidiasis infections [3]. Hyphal and 
yeast growth forms are required for C. albicans virulence (Figure. 1) [2]. C. albicans 
infection treatments have become less effective due to the pathogen’s antifungal drug 
resistance [4]. C. albicans various antifungal drug resistance mechanisms limit 
antifungal treatments’ effectiveness [5]. These mechanisms reduce an antifungal drug’s 
intracellular accumulation and decrease a drug’s affinity or ability to be processed [6]. 
The exact mechanism of drug resistance used will depend upon the treatment 
compound, frequency, and dose concentration [7]. To identify better antifungal drug 
targets and understand filamentous growth, C. albicans biology needs to be better 
understood on a molecular level.
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 Figure 1. C. albicans grows in two forms: yeast and hyphal. 
C. albicans filamentous growth can be induced by a variety of environmental 
conditions such as alkaline pH and high temperature [8]. Once hyphal growth forms 
have developed, the infection is able to spread [9]. If C. albicans enters the 
bloodstream, the cells will spread and grow in other organs, resulting in Candidiasis
[10]. Filamentous growth also leads to biofilm formation, which can be detrimental to 
tissue health and difficult to treat [9].  Research into filamentous growth has been 
focused on genes involved in regulation of filamentous growth progression [11].
One procedure used to better understand protein function is site-directed 
mutagenesis. Site-directed mutagenesis is a process that replaces a wild type DNA 
sequence with a different sequence resulting in an altered version of the protein. 
Alterations in the phenotype are assessed to determine the protein’s function in a 
process [12]. This process has proven difficult in C. albicans for multiple reasons. C. 
albicans has a diploid genome, which means both alleles of a gene need to be modified 
to study the protein’s function [13]. Site-directed mutagenesis commonly uses plasmid 
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vectors to transform gene mutations into cells [14]. Since C. albicans lacks natural 
plasmids, plasmids are not readily maintained by the cells [11] and lower rates of 
successful recombination and transformation occur [15]. 
To get around challenges associated with C. albicans transformation, CRISPR 
(Clustered Regularly-Interspaced Short Palindromic Repeats)-mediated mutagenesis is 
used [16]. The CRISPR system is used in bacteria and archaea as an immune 
response against viruses [17].  When bacteria and archaea with CRISPR are attacked 
by a virus, they retain part of the virus’s DNA and incorporate it into their genome [18]. 
When the surviving cells are attacked later by the same virus, they replicate a guide 
RNA sequence from this incorporated viral DNA. A catalytic enzyme called Cas9 binds 
to this guide RNA, and the guide RNA helps facilitate binding to the invading viral DNA. 
The bound Cas9 cleaves the DNA and disables it [19]. 
Researchers have developed ways to leverage CRISPR technology in various 
multicellular organisms to edit DNA (Figure 2). CRISPR uses the Cas9 enzyme bound 
to a guide RNA to facilitate binding to the homologous DNA and protospacer adjacent 
motif (PAM) site in the target gene. The PAM site serves as the Cas9 targeting site for 
CRISPR [20]. Once bound downstream of the PAM site, Cas9 cleaves the gene and 
leaves the gene inoperable if not repaired. CRISPR-mediated recombination takes 
advantage of this break by using homologous recombination to modify the gene with a 
repair template containing a mutation of interest [21]. 
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 Figure 2. Model of CRISPR-mediated genome editing used to modify C. albicans 
genome. The blue X’s indicate homologous recombination. The mutation is indicated in 
red.
One of the genes associated with filamentous growth that we wanted to apply 
this procedure to is UME6. Ume6 is a transcription factor important for filamentous 
growth and virulence. It controls filamentous growth by regulating expression of genes 
that promote hyphal elongation, germ tube formation, and virulence [22]. Ume6 contains
a Zn2+ finger DNA binding domain between the N-terminal and C-terminal domains 
(Figure 3A) [23]. The goal of this project was to determine if the Zn2+ finger DNA binding
and C-terminal domains are required for filamentous growth regulation. This was done 
by altering residues upstream of the Zn2+ finger DNA binding and C-terminal domains 
(Figures 3B, 3C, and 3D).
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 Figure 3. Cartoon of the Ume6 protein domains. The sites indicated show where 
in the amino acid sequence each mutation was located. A. wild type Ume6. B. 
UME6EE mutation. C. UME6STOP mutation. D. C-terminal domain truncations.
In summary, C. albicans is an opportunistic human fungal pathogen that has the 
potential of developing into a lethal systemic infection called Candidiasis. The immune 
response of a healthy individual is strong enough to prevent bloodstream infection and 
Candidiasis, but an immunocompromised individual is more susceptible. Treatment 
complications arise with C. albicans antifungal drug resistance. These reasons have led
to investigation of C. albicans biology on a molecular level. Site-directed mutagenesis 
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inserts a mutation into a gene to understand the gene’s function. This process has 
proven difficult in C. albicans because of the yeast’s diploid genome and lack of natural 
plasmids. To get around this, we use CRISPR mutagenesis to mutate C. albicans genes
by using Cas9 to cleave a target gene and using homologous recombination to modify 
the gene. We have modified Ume6, a transcription factor important for filamentation, 
using this process to investigate if the Zn2+ finger DNA binding and C-terminal domains 
are required for filamentous growth. 
Methods
C. albicans Cloning and Sequencing
The UME6 guide primers (Table 1) were subcloned into pv1093 [21]. Repair 
templates for all mutations were made using PCR with repair template primers listed in 
(Table 1). Repair templates were purified with a Zymo PCR Purification Kit. C. albicans 
was transformed using a lithium acetate transformation protocol and plated on YPD 
(yeast extract peptone dextrose) media with uridine and 2X nourseothricin (NAT). The 
transformants were grown at 30 °C [24]. Transformants from these plates were streaked
for singles on YPD with uridine and 1X NAT and grown at 30 °C. Colony PCR was 
performed on the single colonies using the primers listed in (Table 1). The colony PCRs 
were resolved on 2% agarose gel treated with ethidium bromide. The colony PCRs 
were screened using restriction digestion with either PacI or BseRI. Restriction digests 
were resolved on a 2% agarose gel treated with ethidium bromide. Successfully 
digested PCRs were sequenced to verify correct genome editing. Correct transformants
were stored at -80 °C for future use. 
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Oligo Name Sequence Restriction Site
Ume6 Guide 2 fr ATTTGtacttctacttctaatccaaG XXX
Ume6 Guide 2 rv AAAACttggattagaagtagaagtaC XXX
Ume6 rp 2_TAA fr aatggcactaacaccaatactgattctacttctacttctaatccaatggtTTAATTAAaa Pac1
Ume2 rp 2_TAA rv tccttttttagatctaggtaataatcttcttcttgtatgtttTTAATTAAaccattggat Pac1
Ume6 rp 2_Glu fr atggcactaacaccaatactgattctacttctacttctaatccaatggtgGAGGAGaaac BseRI
Ume6 rp 2_Glu rv catccttttttagatctaggtaataatcttcttcttgtatgtttCTCCTCcaccattgga BseRI
Ume6trunc1 Fw aaaagaaatcaagctaaaacaaaaattctcggaaaaaatcaagtaatgataTTAATTAA Pac1
Ume6trunc1 Rv ctgttaattcttaattcttaacttagcctaatttcaatcattcaTTAATTAAtatcatta Pac1
Ume6TAA-3 RV gtcaacctgttaattcttaattcttaacttagcctaatttcaatcattgTTAATTAAtat Pac1
Ume6TAA-3 Fw caagctaaaacaaaaatttctcggaaaaaatcaagtaatgataTTAATTAAcaatgat Pac1
Ume6TAA-4 Rv ctgttaattcttaattcttaacttagcctaatttcaatcattgTTAATTAAtcattactt Pac1
Ume6TAA4 Fw aaagaaatcaagctaaaacaaaaatttctcggaaaaaatcaagtaatgaTTAATTAA Pac1
Ume6trunc7 Fw aaaagaaatcaagctaaaacaaaaatttctcggaaaaaatcaagtaatgTTAATTAAt Pac1
Ume6trunc7 Rv ttcttaattcttaacttagcctaatttcaatcaatcattgttaTTAATTAAcattacttg Pac1
Ume6 ch primer 2 fr ggtcatgatcatgatgatgaaaat XXX
Ume6 ch primer 2 rv ctccacaaattggtgtgacttc XXX
ume6-7-8-4 fr gtggaggttgtgctaaattt XXX
ume6-7-8-3 rv ttgttggaatcttctacggg XXX
Table 1. Primers designed to create and verify UME6 C. albicans mutants. Capitalized, bolded, and italicized sequences 
indicate ligation sites at sticky ends in the plasmid. Capitalized and bolded sequences indicate restriction sites. 
9
Growth and Filamentation Assays
Wild type, UME6EE, and UME6STOP C. albicans strains were grown overnight 
in YPD media at 25 °C. The strains were diluted to OD 0.1. Fourfold serial dilutions 
were plated on YPD and Spider media plates with a pin replicator and incubated at 30 
°C and 37 °C overnight [21].
Galleria mellonella Injections
Healthy G. mellonella larvae were randomly assigned into wild type, 
UME6STOP, UME6EE, and phosphate buffered saline (PBS) control groups. Larvae 
were cleaned with ethanol and injected with 105 colony-forming unit (cfu). C. albicans 
wild type or mutant cells. PBS was injected into one group of wax worms to serve as a 
control. The G. mellonella larvae were incubated at 37 °C and observed daily for 
mortality for 7 days. 
 Results
Colony PCR and Restriction Digestion Screening
Ume6 is comprised of three domains hypothesized to be involved with 
filamentous growth regulation. This project focused on understanding the importance of 
the Ume6 Zn2+ finger DNA binding and C-terminal domains. Conserved positively-
charged lysines upstream of the Ume6 Zn2+ finger DNA binding domain were 
substituted with negatively-charged glutamates that altered Ume6 function because of 
the amino acids’ different charges [25]. Truncations upstream of the Ume6 Zn2+ finger 
DNA binding and C-terminal domains were performed to determine if the Ume6 Zn2+ 
finger DNA binding domain is necessary for filamentous growth. Repair templates were 
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designed to modify UME6 upstream of the Zn2+ finger DNA binding and C-terminal 
domains. Purified repair template and plasmid containing the UME6 guides were 
transformed into C. albicans. All transformants were streaked for singles and colony 
PCR was performed. Restriction enzyme digestion was performed on the colony PCR to
screen for the correct incorporation of repair templates (Figure 4). From this, 
transformants were identified that successfully incorporated UME6STOP and UME6EE 
repair templates (Table 2) (Figures 3B and 3C).
Figure 4. Colony PCR and restriction enzyme digest of C. albicans UME6 
transformants. Columns 1A and 1B show colony PCR and digest of UME6STOP with 
Pac1. Columns 2A and 2B show PCR and subsequent digestion of UME6EE with 
BseR1. 
Name Genotype Reference in Text
SC5314 UME6:UME6 wild type
DAB89
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Table 2. C. albicans strains used in the project.
Filamentation Assays
Filamentation assays were performed to determine the effect of glutamate 
substitution and truncation upstream of the Ume6 Zn2+ finger DNA binding domain on 
filamentous growth. Wild type, UME6EE, and UME6STOP cultures were plated on 
Spider media and grown at 30 °C and 37 °C (Figure 5). UME6EE had decreased 
filamentous growth compared to wild type at 30 °C and 37 °C. UME6STOP did not 
filament at 30 °C and 37 °C. Wrinkled colony morphology was less pronounced in 
UME6EE at 30 °C and 37 °C compared to wild type. Wrinkled colony morphology was 
less pronounced in UME6STOP compared to wild type at 37 °C. UME6STOP had 
smooth colony morphology at 30 °C. Using filamentation assays, we found truncations 
and glutamate substitution upstream of the Ume6 Zn2+ finger DNA binding domain 
decreased filamentous growth in C. albicans.
 
Figure 5. Filamentation assay of wild type, UME6EE, and UME6STOP at 30 °C and 37 
°C on Spider media. 
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 wild type
            UME6STOP
Virulence Tests
Virulence tests were performed to determine the Ume6 strains virulence in G. 
mellonella larvae. G. mellonella larvae were used since their innate immune systems 
are like those in mammals. G. mellonella larvae were injected with a PBS control, wild 
type, UME6STOP, or UME6EE and observed daily for one week (Figure 6). Only 20% 
of the G. mellonella larvae treated with the wild type strain survived. 40% of the 
UME6EE-treated G. mellonella larvae survived the infection. UME6STOP-treated G. 
mellonella larvae had approximately 80% of the larvae survive. The PBS control group 
had 95% larvae survival. Overall mortality was decreased in UME6STOP- and 
UME6EE-treated larvae compared to wild type. The UME6STOP larvae exhibited the 
lowest mortality. Using the virulence tests, it was determined that glutamate substitution 
and truncation upstream of the Ume6 Zn2+ finger DNA binding domain decrease 
virulence.
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Figure 6. Survival of G. mellonella larvae injected with wild type, UME6STOP and 
UME6EE strains overtime. 
Ume6 C-Terminal Domain Truncations
The effects on filamentous growth and virulence observed our truncation 
upstream of Ume6 Zn2+ finger DNA binding domain prompted investigation of the Ume6 
C-terminal domain role in filamentous growth. Guide RNAs and repair templates 
truncating one, three, four, and seven amino acids from the Ume6 C-terminal domain 
were designed and transformed into C. albicans (Figure 3D). We did not recover any 








Glutamate substitution and truncation upstream of the Ume6 Zn2+ finger DNA 
binding domain were generated to determine involvement of the Ume6 Zn2+ finger DNA 
binding domain in filamentous growth and virulence. Substitution of two glutamates for 
two conserved lysine residues upstream of the Ume6 Zn2+ finger DNA binding domain 
reduced filamentous growth and virulence compared to wild type C. albicans (Figure 5 
and 6). Truncation upstream of Ume6 Zn2+ finger DNA binding domain eliminated 
filamentous growth (Figure 5) and demonstrated a larger decrease in virulence than 
UME6EE when compared to wild type (Figure 6). Our data supports the hypothesis that 
the Ume6 Zn2+ finger DNA binding domain is important for promoting filamentous 
growth. Zn2+ finger proteins are transcriptional regulators and other C. albicans 
transcriptional regulators involved with filamentous growth regulation, like FGR17 and 
FGR27, contain Zn2+ finger DNA binding domains [26]. Other C. albicans transcriptional 
regulators, like those in the NDT80 family that also contain Zn2+ finger DNA binding 
domains, regulate other processes such as stress response  [27]. Thus, transcriptional 
regulators with Zn2+ finger DNA binding domains are not limited to filamentous growth 
regulation.
The Ume6 Zn2+ finger DNA binding domain is important for filamentous growth 
regulation. We did not know if both the Ume6 Zn2+ finger DNA binding and C-terminal 
domains were required for filamentous growth. I attempted to truncate the Ume6 C-
terminal domain to see if the Zn2+ finger DNA binding domain is sufficient for filamentous
growth regulation. I successfully cloned UME6 guides and made repair templates for 
different Ume6 C-terminal domain truncations. The truncation mutations were not 
present in the transformed C. albicans. Multiple potential reasons exist for why the 
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Ume6 C-terminal domain truncations were not recovered. Previous work in the lab 
introducing stop codons into UME6 has found that a lack of repair template homology 
can inhibit successful genome editing. Homologous recombination efficiency can be 
increased by increasing the size of the homologous region of the repair template and 
increasing the amount of repair template added to the transformation. Increasing repair 
template homology could be done by generating primers that increase homology at 
either end of the repair template. To do this I would have to make longer repair 
templates. This, however, can be cost prohibitive as longer primers cost more to 
produce.
Another possible explanation for why the Ume6 C-terminal domain truncations 
were not present in C. albicans is that truncation of the Ume6 C-terminal domain is 
lethal. One way this could occur is if the C-terminal domain truncation caused a 
dominant negative effect by interaction with essential protein complexes. It has been 
shown that dominant-negative mutations that truncate a protein and leave only  a DNA 
binding domain can turn the protein into a transcriptional inhibitor [28]. Furthermore, 
Ume6 interacts with proteins, such as Ras G family proteins, that are involved with 
multiple signaling pathways [29]. If a dominant-negative effect occurred in a Ume6 C-
terminal truncation mutant, this inhibition could shut down some of these essential 
pathways. Another way Ume6 could be lethal is if the lack of C-terminal domain caused 
random Zn2+ finger DNA binding that is toxic. Alterations to gene expression caused by  
rogue Zn2+ finger binding activity can cause gene reprogramming and unintentional 
transcriptional regulation [30]. For example, this occurs with the testis zinc finger protein
(TZFP) N-terminal domain that regulates generation of virus-specific natural cells in 
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mice. Altered TZFP residues, such as Phe44 or Ser45, alter DNA interactions. This 
results in abnormal virus-specific natural killer cell production [31].
It would be interesting to continue investigation of Ume6 C-terminal domain 
truncations. This project has given supporting evidence that the Zn2+ finger binding 
domain and the Ume6 C-terminal domain regulate filamentous growth. It has not 
verified if the Ume6 Zn2+ finger binding domain is sufficient for filamentous growth 
regulation. Further work needs to be done to verify Ume6 C-terminal domain 
involvement in filamentous growth regulation to better understand the interaction 
mechanisms between Ume6 and the cellular components necessary for filamentous 
growth. Other possible Ume6 C-terminal domain mutations potential amino acid 
substitutions in the C-terminal domain and additional C-terminal domain truncations 
could be made. Glutamate and alanine substitutions and truncations have been 
successfully incorporated into Ume6. Designing mutations upstream of amino acids 
targeted with the Ume6 C-terminal domain truncations attempted in this project could be
challenging as no PAM sites in exist in this portion of UME6. One way around this using
the new CRISPR system Cpf1. Cpf1 utilizes the PAM site TTTN instead of NGG [32]. 
Cpf1 PAM sites are more abundant in Ume6 than Cas9 PAM sites and use of the Cpf1 
PAM sites would help get around the lack of Cas9 PAM sites.
In the future, more work should be done applying CRISPR mutagenesis to other 
C. albicans genes to better understand their involvements with filamentous growth. 
Filamentous growth in yeast occurs when environmental circumstances trigger signaling
pathways that cause cell elongation, reorganized polarity, and increased cell-to-cell 
adhesion [33]. Current lab members are applying CRISPR mutagenesis to UME7, 
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another transcription factor, and various pseudouridine synthase (PUS) genes. While 
Ume7 is thought to act as a transcription factor in C. albicans, a similar Saccharomyces
cerevisiae gene, UME6, regulates meiotic genes [23]. Meiosis is used for reproduction 
in S. cerevisiae, but C. albicans does not perform meiosis [34]. This leads the question 
as to the role of UME7 in C. albicans.
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